NCT04059679: Synergistic Influence of Rivaroxaban on Inflammation and Coagulation Biomarkers in Patients With CAD and PAD on Aspirin Therapy |
|
|
| Recruiting | 4 | 30 | US | Rivaroxaban 2.5 Mg Oral Tablet, Aspirin 81 mg | LifeBridge Health, Janssen Scientific Affairs, LLC | Coronary Artery Disease, Peripheral Artery Disease | 03/21 | 08/21 | | |
| Not yet recruiting | 4 | 78 | Europe | Rivaroxaban, cardioaspirin 100ml, [bay59-7939], [24840074], Tablet, Gastro-resistant tablet, XARELTO - 2,5 MG - COMPRESSE RIVESTITE CON FILM - USO ORALE - BLISTER (PP/ALU) - 56 COMPRESSE, CARDIOASPIRIN - 100 MG COMPRESSE GASTRORESISTENTI30 COMPRESSE | FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE, Bayer S.p.A. | type 2 diabetic patients with stable peripheral or carotid artery disease diabete mellito di tipo 2 e vasculopatia arteriosa periferica o carotidea stabile, na na, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
SPIRIT, NCT05797376: Effects of aSPIrin Versus Aspirin Plus Low-dose RIvaroxaban on Carotid aTherosclerotic Plaque Inflammation |
|
|
| Recruiting | 4 | 92 | RoW | Rivaroxaban 2.5mg, Xarelto 2.5mg | Asan Medical Center, Bayer | Atherosclerosis of Artery, Coronary Artery Disease, Peripheral Arterial Disease, Carotid Stenosis | 12/24 | 06/25 | | |
